Sfoglia per Autore
Pharmacokinetics of colistin methanesulfonate (CMS) in burns patients
2014-01-01 L. Baietto; A. D’Avolio; S. Corcione; V. Malvasio; G. Di Perri; M. Stella; F.G. De Rosa
Daptomycin plasma and CSF levels in patients with external ventricular drain (EVD)-related ventriculo-meningitis (VM)
2014-01-01 L. Baietto; S. Piva; N. Latronico; T. Togni; G. Di Perri; A. D’Avolio
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.
2014-01-01 Calcagno A;Baietto L;Pagani N;Simiele M;Audagnotto S;D'Avolio A;De Rosa FG;Di Perri G;Bonora S
Therapeutic drug monitoring of intracellular anti-infective agents.
2014-01-01 D'Avolio A;Pensi D;Baietto L;Di Perri G
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma
2014-01-01 Marco Simiele;Lorena Baietto;Alessio Audino;Mauro Sciandra;Stefano Bonora;Giovanni Di Perri;Antonio D’Avolio
How effective are the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?
2014-01-01 Baietto L;Simiele M;D'Avolio A
PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE
2014-01-01 Fanelli V; Costamagna A; Persico P; Rotondo G; Mascia L; Corcione S; Baietto L; D'Avolio A; Terragni PP; De Rosa FG; Bonato R; Del Sorbo L; Boffini R; Rinaldi M; Ranieri VM
A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
2014-01-01 Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib.
2013-01-01 E. Pirro; S. De Francia; A. D'Avolio; A. Ariaudo; M. Simiele; J. Cusato; C. Fava; L. Baietto; G. Di Perri; G. Saglio
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
2013-01-01 Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma.
2013-01-01 D'Avolio A;Peila E;Simiele M;Pensi D;Baietto L;Cusato J;Cinnirella G;De Rosa F;Di Perri G
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.
2013-01-01 D'Avolio A;Simiele M;Calcagno A;Siccardi M;Larovere G;Agati S;Baietto L;Cusato J;Tettoni M;Sciandra M;Trentini L;Di Perri G;Bonora S
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH
2013-01-01 De Rosa, FG; Corcione, S; Baietto, L; Pasero, D; Di Perri, G; Ranieri, VM; D'Avolio, A
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation
2013-01-01 De Rosa, FG; Corcione, S; Baietto, L; Ariaudo, A; Di Perri, G; Ranieri, VM; D'Avolio, A
Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment.
2013-01-01 Calcagno A;Baietto L;Pagani N;Bertucci R;Rostagno R;D'Avolio A;Di Perri G;De Rosa FG
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
2013-01-01 Baietto, L; D'Avolio, A; Ariaudo, A; Corcione, S; Simiele, M; Cusato, J; Urbino, R; Di Perri, G; Ranieri, VM; De Rosa, FG.
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D
2013-01-01 Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG;Di Perri G
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
2012-01-01 De Socio G.V.; D’Avolio A.; Sgrelli A.; Baietto L.; Di Perri G.; Baldelli F.
Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population.
2012-01-01 Baietto L;G De Rosa F;Dʼavolio A;Marra C;Pace S;Biasin E;Carraro F;Nesi F;Simiele M;Cusato J;Siccardi M;Di Perri G
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).
2012-01-01 A. D'Avolio;M. Simiele;S. De Francia;A. Ariaudo;L. Baietto;J. Cusato;C. Fava;G. Saglio;F. Di Carlo;G. Di Perri
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pharmacokinetics of colistin methanesulfonate (CMS) in burns patients | 2014 | L. Baietto; A. D’Avolio; S. Corcione; V. Malvasio; G. Di Perri; M. Stella; F.G. De Rosa | |
| Daptomycin plasma and CSF levels in patients with external ventricular drain (EVD)-related ventriculo-meningitis (VM) | 2014 | L. Baietto; S. Piva; N. Latronico; T. Togni; G. Di Perri; A. D’Avolio | |
| Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. | 2014 | Calcagno A;Baietto L;Pagani N;Simiele M;Audagnotto S;D'Avolio A;De Rosa FG;Di Perri G;Bonora S | |
| Therapeutic drug monitoring of intracellular anti-infective agents. | 2014 | D'Avolio A;Pensi D;Baietto L;Di Perri G | |
| A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma | 2014 | Marco Simiele;Lorena Baietto;Alessio Audino;Mauro Sciandra;Stefano Bonora;Giovanni Di Perri;Antonio D’Avolio | |
| How effective are the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring? | 2014 | Baietto L;Simiele M;D'Avolio A | |
| PHISIOLOGIC VARIABLES AND PHARMCOKINETICS IMIPENEM DURING ENLP. A SINGLE CENTER TRANSPLANTATION EXPERIENCE | 2014 | Fanelli V; Costamagna A; Persico P; Rotondo G; Mascia L; Corcione S; Baietto L; D'Avolio A; Terragni PP; De Rosa FG; Bonato R; Del Sorbo L; Boffini R; Rinaldi M; Ranieri VM | |
| A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics? | 2014 | Baietto, L; Corcione, S; Pacini, G; Di Perri, G; D'Avolio, A; De Rosa, FG | |
| Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. | 2013 | E. Pirro; S. De Francia; A. D'Avolio; A. Ariaudo; M. Simiele; J. Cusato; C. Fava; L. Baietto; G. Di Perri; G. Saglio | |
| Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs? | 2013 | Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora | |
| Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma. | 2013 | D'Avolio A;Peila E;Simiele M;Pensi D;Baietto L;Cusato J;Cinnirella G;De Rosa F;Di Perri G | |
| Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. | 2013 | D'Avolio A;Simiele M;Calcagno A;Siccardi M;Larovere G;Agati S;Baietto L;Cusato J;Tettoni M;Sciandra M;Trentini L;Di Perri G;Bonora S | |
| Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH | 2013 | De Rosa, FG; Corcione, S; Baietto, L; Pasero, D; Di Perri, G; Ranieri, VM; D'Avolio, A | |
| Pharmacokinetics of linezolid during extracorporeal membrane oxygenation | 2013 | De Rosa, FG; Corcione, S; Baietto, L; Ariaudo, A; Di Perri, G; Ranieri, VM; D'Avolio, A | |
| Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment. | 2013 | Calcagno A;Baietto L;Pagani N;Bertucci R;Rostagno R;D'Avolio A;Di Perri G;De Rosa FG | |
| Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots | 2013 | Baietto, L; D'Avolio, A; Ariaudo, A; Corcione, S; Simiele, M; Cusato, J; Urbino, R; Di Perri, G; Ranieri, VM; De Rosa, FG. | |
| Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D | 2013 | Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG;Di Perri G | |
| Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs | 2012 | De Socio G.V.; D’Avolio A.; Sgrelli A.; Baietto L.; Di Perri G.; Baldelli F. | |
| Prophylactic drug monitoring of itraconazole in an oncohematological pediatric patient population. | 2012 | Baietto L;G De Rosa F;Dʼavolio A;Marra C;Pace S;Biasin E;Carraro F;Nesi F;Simiele M;Cusato J;Siccardi M;Di Perri G | |
| HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). | 2012 | A. D'Avolio;M. Simiele;S. De Francia;A. Ariaudo;L. Baietto;J. Cusato;C. Fava;G. Saglio;F. Di Carlo;G. Di Perri |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile